Countries covered: Global
This report analyzes the worldwide markets for Cell-Based Assays in US$ Million by the following product segments: Assay Kits (Functional Assays, Cell Death-Associated Assays, & Cell Growth-Associated Assays), and Laboratory Automation. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 73 companies including many key and niche players such as BD Biosciences, Beckman Coulter, Inc., BioVision, Inc., Caliper Life Sciences, Inc., Cisbio Bioassays, DiscoveRx Corporation, Enzo Life Sciences, Inc., Evotec AG, GE Healthcare Life Sciences, Invitrogen Corporation, Millipore Corporation, PerkinElmer, Inc., Promega Corporation, ProQinase GmbH, Qiagen NV, StemCells, Inc., and Thermo Fisher Scientific, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
|
- 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- Assay Kits
- Functional Assays
- Cell Death-Associated Assays
- Cell Growth-Associated Assays
- Lab Automation
- 2. CELL-BASED ASSAYS: A PRIMER
- 3. INDUSTRY OVERVIEW
- Cell-based Assays: A Prelude
- Current and Future Analysis
- Cell-Based Assays Emerge as a Popular Tool in Drug Discovery and Basic Research
- HTS and UHTS (High Throughput Screening or Ultrahigh-throughput Screening Assays)
- Trends in Cell-Based Assay Market
- Growing Inclination Towards In-vitro Assays for Toxicology Studies
- Industry Trends
- Cell-Based Assays: A Leading Drug Discovery Methodology
- Economy of Time and Cost Drives the Use of Cell-Based Assays Over Other Techniques
- Growing Focus on the Development of Reproducible and Robust Cell-based Assays
- HTS and Advancements in the Stem Cell Arena: A Growing Trend
- Increasing Use of Cell-Based Assays over Other Methods in Toxicity Testing
- Functional Assays: An Effective Way of Predicting Specific Toxic Effects
- Rising Interest in Cell-based Assays Propels the Development of Improved Product Offerings
- Automation of Cell-based Assays: A Growing Trend
- Technological Advancements in Drug Discovery Processes Spurs Cell-Based Assay Market
- Development of Label-free Cell-based Assays: A Recent Trend in Biological Assays
- Role of Surface Chemistries
- Limitations
- Microfluidics Systems in Cell-based Assays
- Cell-Based Assays Likely to Gain from Microfluidic Devices
- Other Trends
- 4. CELL-BASED ASSAYS: AN OVERVIEW
- What Drives Advances in Cell-based Assays?
- Cell Culture Fundamentals
- An Insight into Cell Biology
- Cell-based Assays: Basic Facts
- Defining Cell-based Assays
- Assays
- Biological Assays
- Quantification of Biological Activity
- Cell-based Assays
- Cell Based Assays: Prerequisites for Proof Of Concept
- List of Factors to be Considered in Cell-Based Assays
- Contamination with Mycoplasma: A Critical Factor
- Modes of Contamination
- Prevention
- Uses of Cell-Based Assays
- Challenges
- Transient Transfection Cells
- Limitations
- Cell-based Assays: Product Segmentation
- Assay Kits
- Cell Function-Associated Assays
- Cell Growth-Associated Assays
- Cell Death-Associated Assays
- Lab Automation
- MIACA
- Innovations in Cell-based Assays for Screening
- MultiScreen Filter Plates from Millipore
- MultiScreen Filter Plates from Millipore by Type of Assay
- The Road Ahead
- 5. PRODUCT INTRODUCTIONS/LAUNCHES
- ACEA, Roche, and Vivo to Co-develop Novel xCELLigence System Assays
- GE Healthcare and Geron Launch First Human Cardiomyocyte Product
- Biomonitor Unveils Novel Products in iLite™ Product Line
- Biomoda Receives Patent for Assay Use and Formulation
- TGR BioSciences Expands 'No-Wash' SureFire Cellular Kinase Assay Portfolio
- Hamamatsu Launches FDSS/uCELL Imaging Plate Reader
- Nexcelom Bioscience Launches Cellometer® Auto X
- SRU Biosystems Advances Label-free BIND Biosensors Range
- BioTek Instruments Introduces ELx405TM Microplate Bead Washer
- Platypus Technologies Purchases Oris™ Pro Cell Migration Assay
- Millipore Unveils MILLIPLEX® MAP EpiQuantTM Assay Panels
- Corning Launches Osteo-Assay Surface for Bone Cell Assays
- VisEn Medical Introduces Cat B 750 FAST Imaging Agent
- Roche Launches xCELLigence System and FuGENE HD
- Cisbio Bioassays Introduces Cellul'erk
- AnaSpec Launches Calcein Acetoxymethyl Ester
- Patheon Launches Cell-based Assay Services
- Sigma-Aldrich Launches Precisio (TM) Kinases
- CXR Biosciences and Millipore Launch ToxReporter™
- Beckman Coulter Launches Gallios Flow Cytometer
- Cisbio Bioassays Introduces HTRF® Terbium Platform for GPCR Screening
- Corning Launches Integrated LHA for the Epic® System
- PerkinElmer Unveils New AlphaScreen® SureFire® Assays
- Millipore Introduces High Content Kits for Neurotoxicity
- MaxCyte to Unveil MaxCyte STX Scalable Transfection System
- LSG and Gentronix to Launch Human Cell-Based Assays for Genotoxicity in Japan
- Innovatis Introduces Cellavista
- Roche Applied Science Introduces xCELLigence System
- Bravo Introduces Liquid Handling Platform
- Cellix Introduces VenaFlux Platform
- MaxCyte Unveils ITF Inline Transfection System
- Thermo Fisher Scientific Expands Thermo Scientific Stem CELLExcellence Program
- Tecan Group to Introduce New Infinite M1000 Multimode Microplate Reader
- Beckman Coulter Integrates Quanta SC MPL with Cell Culture System
- Genetix Launches CellReporter Cell-Based Assay Platform
- Greiner Bio-One Unveils CELLSTAR® Plates
- PBL InterferonSource Introduces Gene Reporter Cell-Based Assay Kit
- 6. RECENT INDUSTRY ACTIVITY
- Merck Acquires Millipore
- DiscoveRx Acquires KINOMEscan™ Division from Ambit
- Asterand Takes over BioSeek
- LGC Standards Inks Partnership Agreement with Gentronix
- Cellular Dynamics International Partners with Promega
- CCS Cell Culture Service Acquires MaxCyte® STXTM Scalable Transfection System
- Gentronix Inks Three-Year Agreement with GlaxoSmithKline
- DiscoveRx Enters into Co-Marketing Agreement with Jubilant
- Qiagen Takes Over SABiosciences
- Galapagos Signs Agreement with Dart Neuroscience
- Asterand Extends Collaboration with Bristol-Myers Squibb
- Pfizer Extends JAK3 Research Collaboration with Ligand Pharmaceuticals
- StemCells to Expand Cell-Based Assay Platforms
- Caliper Life Sciences to Utilize Label-Free Bind Technology of SRU Biosystems
- O2h Enters into First Biology Affiliate Partnership with Hypoxium
- Evotec and DiscoveRx Ink Agreement to Support HTS Services
- Millipore Takes Over Guava Technologies
- Beckman Coulter and Propel Labs Collaborate for Flow Cytometry
- Beckman Coulter Interfaces CyAn™ Flow Cytometer with IntelliCyt’s HyperCyt®
- XenoBiotic to Establish New Laboratory in China
- StemCells Acquires Stem Cell Sciences
- PerkinElmer Enters into Collaboration with Sangmyung University
- Seahorse Bioscience Takes Over BioProcessors
- Roche Inks Co-development and Marketing Agreement with Axiogenesis
- ChanTest Takes over Applied Cell Sciences
- Emory University Acquires Corning® Epic® System
- Biomonitor Takes Over Neutekbio
- Affymetrix to Take Over Panomics
- BioForce to Ink Agreement with University Pierre & Marie Curie and Centre National de Recherché Scientifique
- Gentronix Inks Agreement with LSG
- Veridex Acquires Immunicon
- Caliper Life Sciences Partners with DiscoveRx
- BioSeek Inks Agreement with Dainippon Sumitomo Pharma
- 3M Takes Over Acolyte Biomedica
- Invitrogen Corporation Acquires BioSource
- Caliper Life Sciences Acquires NovaScreen Biosciences
- 7. FOCUS ON SELECT GLOBAL PLAYERS
- BD Biosciences (US)
- Beckman Coulter, Inc. (US)
- BioVision, Inc. (US)
- Caliper Life Sciences, Inc. (US)
- Cisbio Bioassays (US)
- DiscoveRx Corporation (US)
- EMD Millipore (US)
- Enzo Life Sciences, Inc. (US)
- Evotec AG (Germany)
- GE Healthcare Life Sciences (UK)
- Invitrogen Corporation (US)
- PerkinElmer, Inc. (US)
- Promega Corporation (US)
- ProQinase GmbH (Germany)
- Qiagen NV (The Netherlands)
- StemCells, Inc. (US)
- Thermo Fisher Scientific, Inc. (US)
- 8. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current and Future Analysis for Cell-Based Assays by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
- Table 2: World Historic Review for Cell-Based Assays by Geographic Region - US, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
- Table 3: World 15-Year Perspective for Cell-Based Assays by Geographic Region - Percentage Breakdown of Dollar Sales for US, Japan, Europe, and Rest of World Markets for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)
- 9. THE UNITED STATES
- A. Market Analysis
- Current and Future Analysis
- Laboratory Automation and Assay Kits - Largest Segments by Product Type
- Functional Assays - The Fastest Growing Product Segment
- Cell-Based Assay Market to Witness Significant Growth
- Life Science Remains the Largest End-Use Sector
- Market Trends
- Consolidation Rife in the Industry
- Select Acquisitions in the Industry (2006-2010)
- Increased Usage Drives Growth of Cell-based Assays
- Automation, High-Throughput Screening Pulls Down CBA Market Growth, to a Certain Extent
- Custom Designed Assays to Drive the US Cell-based Assay Market
- Competitive Scenario
- US Functional Cell Assays Market
- Table 4: Leading Players in the US Functional Cell - Based Assays Market (2009): Percentage Breakdown of Revenues for Millipore, Promega, New England Biolabs, Sigma-Aldrich, BD Biosciences and Others (includes corresponding Graph/Chart)
- Table 5: Leading Players in the US Cell-Based Assays Market (2009): Percentage Breakdown of Revenues for Millipore, Promega, EMD Biosciences, BD Biosciences, New England Biolabs and Others (includes corresponding Graph/Chart)
- Table 6: Leading Players in the US Cell Growth-Based Assays Market (2009): Percentage Breakdown of Revenues for Promega, Invitrogen, EMD Biosciences, Millipore, BD Biosciences and Others (includes corresponding Graph/Chart)
- Table 7: Leading Players in the US Cell Death -Based Assays Market (2009): Percentage Breakdown of Revenues for EMD Biosciences, Millipore, BD Biosciences, Invitrogen, Promega and Others (includes corresponding Graph/Chart)
- Product Launches
- Strategic Corporate Developments
- Focus on Select Players
- B. Market Analytics
- Table 8: US Recent Past, Current and Future Analysis for Cell-Based Assays by Product Segment - Assay Kits (Functional Assays, Cell Death-Associated Assays, Cell Growth-Associated Assays) and Laboratory Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
- Table 9: US Historic Review for Cell-Based Assays by Product Segment - Assay Kits (Functional Assays, Cell Death-Associated Assays, Cell Growth-Associated Assays) and Laboratory Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
- Table 10: US 15-Year Perspective for Cell-Based Assays by Product Segment - Percentage Breakdown of Dollar Sales for Assay Kits (Functional Assays, Cell Death-Associated Assays, Cell Growth-Associated Assays) and Laboratory Automation for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)
- 10. JAPAN
- A. Market Analysis
- Current and Future Analysis
- Strategic Corporate Developments
- B. Market Analytics
- Table 11: Japanese Recent Past, Current and Future Analysis for Cell-Based Assays Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
- Table 12: Japanese Historic Review for Cell-Based Assays Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
- 11. EUROPE
- A. Market Analysis
- Current and Future Analysis
- Table 13: European Cell-Based Assay Market by End-Use Sector (2009): Percentage Breakdown of Revenues for Pharmaceuticals, Biotech Companies and Research/ Academia (includes corresponding Graph/Chart)
- Market Outlook
- Cell-Based Assays Continue to Gain Impetus
- GPCR Targets to Drive Growth in Functional Cell Assay Market
- Growth in Cell Growth-Based Assay Kits Trails Behind Other Segments
- Drive Towards Improved Efficiency in Development Programs Provides Impetus to Cell Death Based Assays
- Market Trends
- Rising Number of Drug Targets Surge Demand for Cell-Based Assays
- Laboratory Automation Drives the Growth of European CBA Market
- Cell-based Assays Represent the Primary Drug Discovery Tool in HTS Laboratories
- Advancements in Technology, Identification Methods, and Lab Disciplines in the CBA Market
- Cell-Based Assays: Regulatory Requirements
- Validation Assays for Compliance with ICH Guidelines
- Outsourcing of Validation Studies to CTOs
- Important Considerations for Outsourcing Validation Assays to CTOs
- Competitive Landscape
- Product Launches
- Strategic Corporate Developments
- Focus on Select Players
- B. Market Analytics
- Table 14: European Recent Past, Current and Future Analysis for Cell-Based Assays by Product Segment - Assay Kits (Functional Assays, Cell Death-Associated Assays, Cell Growth-Associated Assays) and Laboratory Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
- Table 15: European Historic Review for Cell-Based Assays by Product Segment - Assay Kits (Functional Assays, Cell Death-Associated Assays, Cell Growth-Associated Assays) and Laboratory Automation Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
- Table 16: European 15-Year Perspective for Cell-Based Assays by Product Segment - Percentage Breakdown of Dollar Sales for Assay Kits (Functional Assays, Cell Death- Associated Assays, Cell Growth-Associated Assays) and Laboratory Automation for Years 2003, 2010 and 2017 (includes corresponding Graph/Chart)
- 12. REST OF WORLD
- A. Market Analysis
- Current and Future Analysis
- Product Launch
- Strategic Corporate Developments
- B. Market Analytics
- Table 17: Rest of World Recent Past, Current and Future Analysis for Cell-Based Assays Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2017 (includes corresponding Graph/Chart)
- Table 18: Rest of World Historic Review for Cell-Based Assays Independently Analyzed with Annual Sales Figures in US$ Million for Years 2003 through 2008 (includes corresponding Graph/Chart)
- COMPETITIVE LANDSCAPE
- Total Companies Profiled: 73 (including Divisions/Subsidiaries - 79) Region/Country Players
- The United States 60
- Europe
- France
- Germany
- The United Kingdom
- Rest of Europe 7
- Asia-Pacific (Excluding Japan) 1
More Global Molecular Assays Reports
IVD Market Research Bundle (In Vitro Diagnostic Test Markets, BRIC and Other Regional Markets, Biomarker Testing and Other Pharmacodiagnostics) by
Kalorama Information
What does the diagnostic market look like today, how is the continuing economic news effecting the market, and what are companies doing right now to ...
Global Molecular Diagnostics Market & Future Forecast 2010 - 2014 by
Renub Research
Global Molecular Diagnostics - Market Overview
The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different ...
Companion Diagnostics: Technologies and Global Markets by
BCC Research
Oncotype Dx, although not FDS-approved, is still a lead product in the breast cancer diagnosis sector. Oncotype Dx is reimbursed by most insurance companies ...
Molecular Diagnostics by
Global Industry Analysts
This report analyzes the worldwide markets for Molecular Diagnostics in US$ million by the following segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening. The report ...
Global Molecular Diagnostics Market 2009-2013 by
Infiniti Research Limited
Molecular Diagnostics is the clinical application of molecular biology technologies, used in disease management. It consists of screening and diagnostics tests - using genetic material ...
See all reports like this >>
Share this report
Other tasks Related Markets Molecular Assays Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
